Skip to main content
. 2018 Jun 30;39(10):1304–1309. doi: 10.1093/carcin/bgy091

Figure 4.

Figure 4.

The methylome of the formed xenograft tumours is stable. (A) Hierarchical clustering of methylation β-values for 27 500 CpG sites, with standard deviation across samples above 0.25, groups the three samples (T – tumour, C – cell line and X – xenograft) from the same origin together for all cases. (B) Percentage of probes that change methylation status, defined as a difference in β-values >0.51 between xenograft and tumour (T) and cell line (C), respectively, was below 3% in all cases.